K-Dense-AI/scientific-agent-skills / skills/iso-standards-readiness
iso-standards-readiness
VerifiedPrepares and structurally reviews readiness evidence for ISO management-system and laboratory-competence standards - ISO 13485 medical device QMS, ISO 14971 device risk management, ISO/IEC 17025 testing and calibration laboratories, and ISO 15189 medical laboratories. Use when organizing declared scope, controlled documents, risk-management files, scope of accreditation, traceability, CAPA, external-provider controls, or bounded local evidence manifests, and when separating ISO certification from laboratory accreditation, FDA QMSR inspection, CLIA certification, MDSAP, and EU MDR/IVDR evidence boundaries. Not for legal applicability, compliance, certification, or accreditation decisions; contains no clause text.
references/iso-15189.md
View on GitHub# ISO 15189 Process Framework (No Standard Text)
Research basis: **2026-10-01**. This reference summarizes a preparation process and
evidence architecture for medical laboratory quality and competence work. It does not
reproduce requirements and is not a substitute for the standard.
## Copyright and authorized access
ISO publications are copyrighted. Obtain ISO 15189 from
[ISO](https://www.iso.org/standard/76677.html), an ISO national member, or another
authorized source; see [ISO copyright](https://www.iso.org/copyright.html). Do not ask
an agent to retrieve, transcribe, summarize clause-by-clause, or store proprietary
text. Accreditation-body and CAP checklists that quote requirements are separately
licensed material — do not paste them into shared repositories or prompts.
## Current edition and the closed transition
- [ISO 15189:2022](https://www.iso.org/standard/76677.html) is Edition 4, published
December 2022, cancelling and replacing ISO 15189:2012; catalogue metadata was
read directly for this review.
- The 2022 edition aligns structurally with ISO/IEC 17025:2017 and **incorporates
point-of-care testing requirements previously held in ISO 22870**. Do not cite
ISO 22870:2016 as a current separate basis: the ISO catalogue lists it as withdrawn.
- The ILAC-agreed transition for accredited medical laboratories ran to **December
2025**. A 2012-based quality system is out of date, not "in transition" — do not
build a gap baseline that assumes a future deadline.
- Record publisher, title, edition, amendments, authorized location, access date,
source owner, currency-review date, impact decision, and approval in the controlled
source ledger.
## Keep four lanes separate
### 1. ISO 15189 accreditation
An accreditation body grants accreditation for a defined scope of examinations, per
laboratory and per location, under ISO/IEC 17011. A medical laboratory is
**accredited**, not "ISO 15189 certified." Since 2026-01-01 the recognition arrangement
sits with Global Accreditation Cooperation Incorporated; verify current claim and logo
wording with the accreditation body.
### 2. United States CLIA certification
CLIA covers US human-specimen testing for diagnosis, prevention, treatment, or
health assessment. Applicable laboratories need the appropriate CLIA certificate
or an applicable exemption. Under [42 CFR 493.3](https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-493/subpart-A/section-493.3),
research testing without patient-specific results for those clinical purposes is an
explicit exception. This does not make every research-labelled study exempt: the
authorized owner must evaluate the actual testing and reporting purpose.
**ISO 15189 accreditation does not satisfy CLIA and cannot replace a CLIA-based
accreditation.** Deemed status flows only from a CMS-approved accreditation
organization's program. CMS approves a limited set of accreditation organizations whose
approved programs support the CLIA accreditation route; read the
[current AO list](https://www.cms.gov/media/678411)
rather than relying on a remembered count. The CAP 15189 program is layered on top of
CAP Laboratory Accreditation Program accreditation rather than offered as a standalone
substitute. CAP's current program page also excludes POCT from the CAP 15189
program scope and keeps a quality-manual requirement. These are scheme-specific
conditions; ISO 15189's broader POCT coverage does not override them.
Never let an ISO 15189 readiness output be read as CLIA compliance, deemed status,
licensure, or an inspection result.
### 3. Other national licensure and inspection regimes
State licensure, national health-authority requirements, and payer conditions of
participation are separate again, with their own inspection processes and their own
records. Non-US jurisdictions may make ISO 15189 accreditation mandatory, voluntary, or
irrelevant. This is an applicability decision for authorized humans.
### 4. IVD device regulation
The performance of an in vitro diagnostic device, and any laboratory-developed test
regime that applies to it, is regulated separately from laboratory accreditation. EU
IVDR conformity assessment, notified-body involvement, and performance-study
requirements are not laboratory accreditation questions. See `references/iso-13485.md`
and the EU entries in `references/source-ledger.md`.
## Hard boundary
This skill and its files cannot:
- accredit a laboratory, issue or validate an accreditation certificate or schedule,
or predict an assessment or inspection outcome;
- establish CLIA certification, deemed status, licensure, or personnel qualification;
- decide which scheme, jurisdiction requirement, or payer condition applies;
- replace the laboratory director, quality manager, authorized signatory,
accreditation body, assessor, EQA provider, or competent authority;
- verify or validate an examination procedure, set biological reference intervals,
establish traceability of assigned values, or judge clinical suitability; or
- infer competence or patient safety from a document title, keyword, template,
checklist, or script result.
Use outputs as a list of evidence questions for accountable human review.
## Scope of accreditation is per examination
Each scope item is defined by discipline, the examination or measurand reported, the
controlled procedure and its issue, and the primary sample type with its acceptance
requirements. Point-of-care testing performed under the laboratory's responsibility
belongs in the scope discussion explicitly, including devices operated by clinical
staff outside the laboratory.
```bash
PYTHONDONTWRITEBYTECODE=1 python3 scripts/validate_scope_intake.py \
/path/to/medical-laboratory-scope-intake.json --standard iso-15189
```
Copy `assets/templates/medical-laboratory-scope-intake-template.json` outside the skill
first. The distributed template fails closed by design.
## Process and evidence domains
The `iso-15189` profile carries these domain labels for manifests and gap reports.
They are workflow topics, not clause references:
`scope-and-impartiality`, `organizational-structure-and-governance`,
`personnel-competence`, `facilities-and-safety`, `equipment-and-calibration`,
`metrological-traceability`, `reagents-and-consumables`,
`externally-provided-products-and-services`, `pre-examination-processes`,
`examination-methods-verification-and-validation`, `measurement-uncertainty`,
`validity-of-results-and-external-quality-assessment`, `point-of-care-testing`,
`post-examination-and-reporting`, `laboratory-information-management`, `complaints`,
`nonconformity-and-corrective-action`, `risk-management-and-improvement`,
`internal-audit`, `management-review`, `continuity-and-emergency-preparedness`.
Each domain needs an owner, status, evidence IDs, source/version reference, recorded
approval, and links to open gaps. Sample **records**, not only procedures.
## Where medical laboratory evidence differs from ISO/IEC 17025
### Pre-examination processes carry disproportionate risk
Most avoidable patient harm originates before the analyser: request content and
patient identification, collection and identification of the primary sample, transport
and stability conditions, acceptance and rejection criteria, and handling of
compromised samples. Sample: rejection records, identification-error events, transport
excursions, and the resulting investigations — not only the collection manual.
### Post-examination and reporting is clinical communication
Assemble evidence for result review and authorization, reference intervals and
clinical decision limits with their basis, interpretive comments and who is authorized
to make them, report content and amendment or retraction handling, and — the item most
often thin — **critical-result notification with documented read-back and
timeliness**. Turnaround-time monitoring belongs here too.
### Point-of-care testing needs an explicit standard and scheme scope
ISO 15189:2022 covers POCT, but a chosen accreditation program may limit its
offered scope (including CAP 15189, above). Record the applicable route and the
actual scope schedule; do not infer POCT accreditation from the standard alone.
Record governance of devices outside the
laboratory, operator training and authorization, connectivity and result capture into
the patient record, quality-control regimes, and reconciliation with central
laboratory methods.
### Verification is the normal case, validation the exception
Most medical laboratories verify commercial IVD examinations for their own setting
rather than validating a new method. Record which performance characteristics were
verified against the manufacturer's claims, the acceptance criteria, the data, and the
authorized approval to report patient results. Laboratory-developed and modified
procedures need the fuller validation evidence and the applicable regulatory analysis.
### External quality assessment, not just proficiency testing
Record EQA enrolment per scope item, results, evaluation against criteria, and
investigation of unsatisfactory performance. Where no EQA scheme exists for an
examination, record the alternative comparison approach and its authorization. An
unacceptable EQA outcome with no documented investigation is a blocker.
### Metrological traceability of assigned values
For measurands where higher-order reference materials and reference measurement
procedures exist, record the traceability of assigned values and the resulting
commutability and comparability limitations. Where no reference system exists, record
that fact and what the laboratory does about result comparability.
### Risk and continuity are explicit
The 2022 edition treats risk to patients as a running requirement rather than an annex.
Record identified risks, controls, residual acceptance with authority, and improvement
actions. Continuity and emergency preparedness — instrument failure, LIS outage,
reagent supply interruption, facility loss — needs tested arrangements, not a plan
nobody has exercised.
## Shared checks that apply here
- `scripts/audit_document_records.py` — controlled documents, records, retention basis,
and external-source currency. Standard-agnostic.
- `scripts/check_capa.py` — nonconformity and corrective action with effectiveness
evidence before closure.
- `scripts/check_supplier_controls.py` — reagents, consumables, calibration providers,
and referral laboratories, including the referral laboratory's own accreditation or
licensure status.
- `scripts/validate_evidence_manifest.py` and `scripts/gap_analyzer.py` with
`--standard iso-15189`.
`scripts/check_traceability.py` and `scripts/check_qmsr_transition.py` are
device-lifecycle checks and do not apply here.
## Common preparation failures
- Presenting ISO 15189 readiness as CLIA compliance or deemed status.
- Saying "certified" when the laboratory is accredited.
- Citing ISO 22870 as the current separate POCT basis, or ISO 15189:2012 as current.
- POCT devices operating outside the laboratory with no governance, training, or QC
evidence in the accreditation scope discussion.
- Critical-result notification procedures with no notification records or timeliness
evidence.
- Reference intervals adopted from a package insert with no documented basis for the
served population.
- EQA scores filed without investigation of unsatisfactory results.
- Continuity plans that have never been exercised.
## Sources
- [ISO 15189:2022](https://www.iso.org/standard/76677.html) — catalogue entry
- [ILAC: ISO 15189:2022 published](https://ilac.org/latest_ilac_news/iso-151892022-for-medical-labs-published/)
- [CMS CLIA program](https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments)
- [CLIA accreditation and exemptions](https://www.cms.gov/medicare/health-safety-standards/clinical-laboratory-improvement-amendments-clia/getting-started-clia/understanding-clia-certification-accreditation-test-complexity)
- [CMS approved accreditation organizations](https://www.cms.gov/media/678411)
- [CAP 15189 program](https://www.cap.org/laboratory-quality-solutions/accreditation/cap-15189-accreditation-program/cap-15189-accreditation-process/)
- `references/source-ledger.md` — dated baseline and provenance limitations
- `references/assurance-lanes.md` — how accreditation, certification, and regulatory
inspection differ
Related skills
| Skill | Stars | Updated | Works with | Status | Install |
|---|---|---|---|---|---|
| finishing-a-development-branchobra/superpowersUse when implementation is complete, all tests pass, and you need to decide how to integrate the work | Stars: 323k | Updated | Claude CodeCodex | Verified | Install |
| systematic-debuggingobra/superpowersUse when encountering any bug, test failure, or unexpected behavior, before proposing fixes | Stars: 323k | Updated | Claude CodeCodex | Verified | Install |
| test-driven-developmentobra/superpowersUse when implementing any feature or bugfix, before writing implementation code | Stars: 323k | Updated | Claude CodeCodex | Verified | Install |
| skill-creatoranthropics/skillsCreate new skills, modify and improve existing skills, and measure skill performance. Use when users want to create a skill from scratch, edit, or optimize an existing skill, run evals to test a skill, benchmark skill performance with variance analysis, or optimize a skill's description for better triggering accuracy. | Stars: 198k | Updated | Claude CodeCodex | Verified | Install |